North Dakota 2025-2026 Regular Session

North Dakota House Bill HB1203

Introduced
1/10/25  
Refer
1/10/25  
Report Pass
1/28/25  
Engrossed
2/5/25  
Refer
2/13/25  
Report Pass
4/1/25  

Caption

Definitions of medical marijuana products.

Impact

If enacted, HB 1203 would amend existing laws within the North Dakota Century Code, specifically focusing on the definition and regulation of edible medical marijuana products. The bill would introduce new requirements for dispensaries and manufacturing facilities regarding their ability to produce and sell cannabinoid edibles, ultimately elevating the standards to prevent potential misuse and ensuring product safety. Additionally, it mandates that marketing approaches do not target minors, thereby strengthening consumer protection measures.

Summary

House Bill 1203 aims to regulate the manufacturing, marketing, packaging, and labeling of cannabinoid edible products within North Dakota. The bill establishes stringent requirements for cannabinoid edibles, including specifying that their packaging must be resealable, child-resistant, and opaque to prevent visibility of the product. It also sets a maximum concentration of tetrahydrocannabinol (THC) in each serving and total package amount at fifty milligrams. This legislation is a response to concerns about the safety and marketing of edible marijuana products, particularly their appeal to minors.

Sentiment

The sentiment around HB 1203 appears to be generally supportive among legislators who recognize the need for better regulation of edible cannabinoids, particularly in safeguarding youth from potential harm. However, there may be some contention around the implications of these regulations for manufacturers and dispensaries, who might perceive the bill as an added burden. The balance between ensuring public safety and allowing businesses to operate freely is a significant theme in discussions regarding this bill.

Contention

Notable points of contention may arise over the stringent restrictions placed on the marketing and packaging of cannabinoid products. Some industry advocates could argue that such regulations could stifle business growth and limit consumer choices. Conversely, advocates for youth protection may see these regulations as necessary steps towards responsible consumption practices in the expanding market for medical marijuana. Overall, HB 1203 represents an essential legislative step towards clarifying and enhancing the regulatory framework surrounding cannabinoid edibles in North Dakota.

Companion Bills

No companion bills found.

Similar Bills

ND SB2294

Allowable amounts of usable medical marijuana, medical marijuana recordkeeping, cannibinoid edible products, patient qualifications, and disclosure of information.

MT SB461

Generally revise administration of drug and substance laws

OR SB556

Relating to cannabis; prescribing an effective date.

MA S99

For cannabis market modernization

MA H158

For cannabis market modernization

OR SB1144

Relating to cannabis.

MN HF1254

Manufacture of certain products for sale outside of Minnesota provided, tetrahydrocannabivarin designated as a nonintoxicating cannabinoid, potency limits modified, social equity ownership requirements lowered to 51 percent, manufacturing limits established, and cannabis cultivator license authorizations clarified.

VA HB2775

Hemp product; clarifies definition.